Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

VIPR2 activation has an inhibitory effect on ILC3

ABSTRACT: VIPR2 activation has an inhibitory effect on ILC3

PROVIDER: PRJNA589976 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10467406_1.fastq.gz	Fastqsanger.gz
	SRR10467406_2.fastq.gz	Fastqsanger.gz
	SRR10467407_1.fastq.gz	Fastqsanger.gz
	SRR10467407_2.fastq.gz	Fastqsanger.gz
	SRR10467408_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

VIPR2 activation has an inhibitory effect on ILC3

Project description:We report that VIPR2 is an inhibitory receptor for CCR6+ ILC3

2019-12-19 | GSE140502 | GEO

Trained ILC3 Responses Promote Intestinal Defense

Project description:Group 3 innate lymphoid cells (ILC3) are innate immune effectors that contribute to host defense. Whether ILC3 functions are stably modified following pathogen encounter is unknown. Here we assess the impact of a time-restricted enterobacterial challenge to long-term ILC3 activation. We found that intestinal ILC3 persist for months in an activated state following exposure to Citrobacter rodentium. Upon rechallenge, these “trained” ILC3 proliferate, display enhanced interleukin (IL)-22 responses, and have a superior cell-intrinsic capacity to control infection compared to naïve ILC3. Metabolic changes occur in C. rodentium-exposed ILC3 but only trained ILC3 have enhanced proliferative capacity that contributes to elevated IL-22 production. Accordingly, a limited encounter with a pathogen can promote durable phenotypic and functional changes in intestinal ILC3 that contribute to long-term mucosal defense.

2022-01-31 | GSE191167 | GEO

STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation

Project description:STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation

| PRJNA510664 | ENA

STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation [array]

Project description:STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation [array]

| PRJNA510667 | ENA

GNPS - Caffeine Inhibitory Effect on Catalase

Project description:Investigation of possible inhibitory effect of caffeine on catalase for dopamine conversion into salsolinol. Analyzed with 5 cm C18 column and a 6.5 minutes gradient elution.

2024-03-01 | MSV000094218 | GNPS

STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation [RNA-Seq]

Project description:STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation [RNA-Seq]

| PRJNA510663 | ENA

Genome wide binding of Ahr in ILC3 [ChIP-seq]

Project description:Iron metabolism is pivotal for cell fitness in the mammalian host. However, its role in group 3 innate lymphoid cells (ILC3s) is unknown. Here we show that transferrin receptor CD71-mediated iron metabolism cell-intrinsically controls ILC3 maintenance, cytokine production and host protection against Citrobacter rodentium infection, and metabolically affects mitochondrial respiration by switching of oxidative phosphorylation toward glycolysis. Iron deprivation or Tfrc deficiency reduces the expression and/or activity of the aryl hydrocarbon receptor (Ahr), a ligand-dependent transcription factor and a key ILC3 regulator. Furthermore, consistent with its role in generation of Ahr ligand, microbiome exerts a negative impact on CD71 expression in an Ahr-dependent manner. Genetic ablation or activation of Ahr in ILC3s leads to CD71 upregulation or downregulation, respectively, suggesting an active suppression of CD71 by Ahr. Iron overload partially restores defective ILC3 compartment in the small intestine of Ahr-deficient mice, representing compensatory action of CD71 upregulation during Ahr deficiency. Mechanistically, Ahr directly binds to the promoter region of the Tfrc locus to inhibit Tfrc transcription. These data collectively demonstrate an under-appreciated role of the Ahr-CD71-iron axis in regulation of ILC3 maintenance and function.

2023-07-10 | GSE222008 | GEO

Transcriptional characterization of intestinal ILC3 lacking BMAL1

Project description:Small intestinal group 3 innate lymphoid cells (ILC3) from ILC3-conditional BMAL1 knock out mice or littermate control mice were sort-purified for transcriptional analysis

2019-08-28 | GSE135359 | GEO

IL-15 sustains IL-7R independent ILC2 and ILC3 development

Project description:ILC3 contain 3 well-defined subsets, CCR6+ ILC3, NKp46+ ILC3, and CCR6–NKp46– DN ILC3. These subsets had not previously been transcriptionally compared and the extent to which they had shared or unique transcriptional profiles remained unclear. We used microarray to determine transcriptional differences between these 3 subsets and to find putative factors that support the survival of CCR6+ ILC3 during cytokine depletion.

2017-02-10 | GSE92693 | GEO

Transcriptional impact of iron in ILC3 [RNA-seq]

2023-07-10 | GSE222619 | GEO